Clinical trial NCT05255380: Examine the Effects of Mindfulness in Woman With a History of Child Adversity
Official title: Pilot Randomized Controlled Trial Examining the Effects of Daily Mindfulness in Woman With a History of Child Adversity
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Stress
Psychological Stress
Child Maltreatment
Depressive Symptoms
Signs and Symptoms
Keywords: Mindfulness
Adverse childhood experiences
Stress
Depressive symptoms
Lead sponsor: University of California, San Francisco
Sponsor class: OTHER
Collaborators: name: National Institute on Aging (NIA)
First posted: 2022-02-24
Enrollment: 72
Sex: FEMALE
Minimum age (years): 30
Maximum age (years): 50
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Participants are assigned to either a Mindful Activity group or a Mindful Awareness group. Randomization will occur by chance (50%) at the end of the baseline visit.
Primary purpose: BASIC_SCIENCE

Brief summary: The aim of this pilot Randomized Controlled Trial (RCT) is to test whether brief mindfulness-based practices will improve well-being and health in women (age 30-50) with a history of early life adversity. Following a baseline visit (remotely via Zoom), participants are randomized (50% probability) to either a Mindful Activity group or a Mindful Awareness group. In the Mindful Activity group, participants will complete brief (approximately 5-10 min) audio-guided mindfulness practices twice a day (morning and evening) for 8 weeks using the study app. This is followed by a brief survey about their current thoughts and feelings. In the Mindful Awareness group, participants are asked to be mindful (pay attention) to their thoughts and feelings twice a day (morning and evening) for 8 weeks using the study app. After the 8-week intervention period, all participants complete a follow-up visit (remotely). Primary goals of the pilot RCT are to test acceptability, feasibility, and adherence.

Detailed description: The pilot Randomized Controlled Trial (RCT) randomly assigns midlife women (age 30-50) with a history of early life adversity to either a Mindful Activity group or a Mindful Awareness group to primarily test acceptability, feasibility, and adherence. Randomization will occur by chance at the end of the baseline visit.

Participants randomized to the Mindful Activity group will receive 8 weeks of ecological momentary assessment and intervention sessions via the study app. Mindfulness-based interventions consist of mindfulness and compassion-based practices. For example, practices focus on the breath/body (e.g., 3-minute breathing space; compassionate body scan; five senses mediation), on increasing participants' inner resources (e.g., imaging a safe person or safe place), on reducing negative affect (e.g., self-compassionate and acceptance-based practices), or on increasing positive emotions (e.g., gratitude practice; metta practices). All interventions are audio-guided and approximately 5-10 minutes. Participants complete two mindfulness interventions/day (one in the morning; one in the evening). After completing a mindfulness-based intervention, participants will complete ecological momentary assessments of their current psychological stress states (e.g., stress appraisals, affect, perseverative cognitions, self-criticism, social connection) via the study app.

Participants randomized to the Mindful Awareness group are instructed to be mindful (pay attention) to their current thoughts and feelings and complete ecological momentary assessments of their current psychological stress states (e.g., stress appraisals, affect, perseverative cognitions, self-criticism, social connection) twice/day (morning and evening) for 8 weeks via the study app.

A trained research assistant will monitor participant adherence and address potential difficulties. All participants will complete assessments at baseline (pre-intervention) and post-intervention (after the 8-week intervention). Weekly measures of depressive symptoms are also obtained. The investigators plan to consent about 100 participants with the goal of having 70 eligible participants enrolled in the study (about 35 in each group).

Eligibility criteria: Inclusion Criteria:

1. female sex and gender identity (to control for sex and gender differences in stress responses and health outcomes)
2. age 30-50 (to examine intervention effects on health outcomes in midlife)
3. ≥2 Adverse Childhood Experiences (to ensure exposure to early life adversity)
4. mild depressive symptoms (to allow for outcome improvements: PHQ-9 ≥ 5)
5. having a smartphone (to access app-based assessments/interventions)

Exclusion Criteria:

1. Non-English speaker or unable to provide informed consent
2. Current regular mindfulness practice (exclude if \>20 min/week)
3. Major psychiatric condition, including psychosis/schizophrenia, bipolar disorder, post-traumatic stress disorder, eating disorders, alcohol/substance use, major depression (PHQ-9 ≥ 15), and self-harm or suicidal ideation
4. Major medical conditions, including no history of coronary heart disease, diabetes, severe asthma or lung disease, autoimmune disorders, infectious disease, epilepsy, brain injury, endocrine disorders, diagnosis of cancer or chemotherapy or radiation in the past 10 years
5. Free from medications known to affect the immune and endocrine systems with the exception of antidepressant medication and oral contraceptives
6. Psychotherapy treatment permitted if stable (≥3 months)
7. Current smoking and nicotine use
8. Currently pregnant

Primary outcomes:
measure: Acceptability of the intervention will be measured with an adapted version of the Treatment Acceptability Questionnaire (TAQ).
timeFrame: Assessed at post-intervention, approximately 8 weeks from baseline
measure: Feasibility, as indicated by numbers of participants screened (completed web-based screener and phone screener), eligible based on web-based screener and phone screener, consented, randomized to treatment, and retained at follow-up.
timeFrame: Anticipated study period of 12 months
measure: Adherence, as measured by the percentage of assigned and completed intervention group practices.
timeFrame: Baseline to follow-up, an anticipated 8 weeks
Secondary outcomes:
measure: Change in depressive symptoms, as measured by the total score on the 9-item Patient Health Questionnaire (PHQ-9).
timeFrame: Baseline to post-intervention, an anticipated 8 weeks
Other outcomes:
Locations:
city: San Francisco
country: United States
facility: University of California, San Francisco
state: California
Study officials:
affiliation: University of California, San Francisco
name: Stefanie E Mayer, PhD
role: PRINCIPAL_INVESTIGATOR
References: